Kalhor K, Chen C, Lee H, Cai M, Nafisi M, Que R
Nat Commun. 2024; 15(1):2511.
PMID: 38509069
PMC: 10954689.
DOI: 10.1038/s41467-024-46437-y.
Kalhor K, Chen C, Lee H, Cai M, Nafisi M, Que R
bioRxiv. 2023; .
PMID: 37645998
PMC: 10462101.
DOI: 10.1101/2023.08.16.553610.
Pospiech E, Pisarek A, Rudnicka J, Noroozi R, Boron M, Masny A
Clin Epigenetics. 2023; 15(1):128.
PMID: 37563670
PMC: 10416531.
DOI: 10.1186/s13148-023-01545-2.
Tost J
Adv Exp Med Biol. 2022; 1389:395-469.
PMID: 36350519
DOI: 10.1007/978-3-031-11454-0_16.
Rajpal V, Rathore P, Mehta S, Wadhwa N, Yadav P, Berry E
Front Cell Dev Biol. 2022; 10:1020958.
PMID: 36340045
PMC: 9628676.
DOI: 10.3389/fcell.2022.1020958.
Simple Detection of DNA Methyltransferase with an Integrated Padlock Probe.
Wang Y, Han Y, Zhou F, Fan T, Liu F
Biosensors (Basel). 2022; 12(8).
PMID: 35892466
PMC: 9332213.
DOI: 10.3390/bios12080569.
An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency.
Biezuner T, Brilon Y, Arye A, Oron B, Kadam A, Danin A
NAR Genom Bioinform. 2022; 4(1):lqab125.
PMID: 35156021
PMC: 8826764.
DOI: 10.1093/nargab/lqab125.
Laboratory methods to decipher epigenetic signatures: a comparative review.
Halabian R, Arshad V, Ahmadi A, Saeedi P, Azimzadeh Jamalkandi S, Alivand M
Cell Mol Biol Lett. 2021; 26(1):46.
PMID: 34763654
PMC: 8582164.
DOI: 10.1186/s11658-021-00290-9.
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA.
Kerachian M, Azghandi M, Mozaffari-Jovin S, Thierry A
Clin Epigenetics. 2021; 13(1):193.
PMID: 34663458
PMC: 8525023.
DOI: 10.1186/s13148-021-01182-7.
Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson's disease.
Gordevicius J, Li P, Marshall L, Killinger B, Lang S, Ensink E
Nat Commun. 2021; 12(1):5134.
PMID: 34446734
PMC: 8390554.
DOI: 10.1038/s41467-021-25474-x.
A Comparative Overview of Epigenomic Profiling Methods.
Mehrmohamadi M, Sepehri M, Nazer N, Norouzi M
Front Cell Dev Biol. 2021; 9:714687.
PMID: 34368164
PMC: 8340004.
DOI: 10.3389/fcell.2021.714687.
5-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia Cells.
Reilly B, Luger T, Park S, Lio C, Gonzalez-Avalos E, Wheeler E
Mol Cancer Res. 2020; 19(3):451-464.
PMID: 33172974
PMC: 7925369.
DOI: 10.1158/1541-7786.MCR-20-0453.
STAMP: a multiplex sequencing method for simultaneous evaluation of mitochondrial DNA heteroplasmies and content.
Guo X, Wang Y, Zhang R, Gu Z
NAR Genom Bioinform. 2020; 2(4):lqaa065.
PMID: 33134911
PMC: 7573736.
DOI: 10.1093/nargab/lqaa065.
Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective.
Marshall L, Killinger B, Ensink E, Li P, Li K, Cui W
Nat Neurosci. 2020; 23(10):1203-1214.
PMID: 32807949
DOI: 10.1038/s41593-020-0690-y.
Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels.
Lam D, Luu P, Song J, Qu W, Risbridger G, Lawrence M
Clin Epigenetics. 2020; 12(1):90.
PMID: 32571390
PMC: 7310104.
DOI: 10.1186/s13148-020-00880-y.
DNA methylation markers in the diagnosis and prognosis of common leukemias.
Jiang H, Ou Z, He Y, Yu M, Wu S, Li G
Signal Transduct Target Ther. 2020; 5(1):3.
PMID: 32296024
PMC: 6959291.
DOI: 10.1038/s41392-019-0090-5.
Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons.
Li P, Ensink E, Lang S, Marshall L, Schilthuis M, Lamp J
Genome Biol. 2020; 21(1):61.
PMID: 32151270
PMC: 7063821.
DOI: 10.1186/s13059-020-01960-1.
DNA Methylation Cancer Biomarkers: Translation to the Clinic.
Locke W, Guanzon D, Ma C, Liew Y, Duesing K, Fung K
Front Genet. 2019; 10:1150.
PMID: 31803237
PMC: 6870840.
DOI: 10.3389/fgene.2019.01150.
The Model of the Conserved Epigenetic Regulation of Sex.
Piferrer F, Anastasiadi D, Valdivieso A, Sanchez-Baizan N, Moraleda-Prados J, Ribas L
Front Genet. 2019; 10:857.
PMID: 31616469
PMC: 6775248.
DOI: 10.3389/fgene.2019.00857.
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes.
Reilly B, Tanaka T, Diep D, Yeerna H, Tamayo P, Zhang K
Blood Adv. 2019; 3(19):2845-2858.
PMID: 31582393
PMC: 6784525.
DOI: 10.1182/bloodadvances.2019000192.